123 related articles for article (PubMed ID: 38350551)
1. Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical Management.
Faidley KN; Botkin HE; Loeffler BT; Mott SL; Hansen SC; Hill EK; Erickson BA
Urology; 2024 Apr; 186():101-106. PubMed ID: 38350551
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Outcomes from Conservative Management of Cervical Cancer Associated Ureteral Obstruction.
Botkin HE; Faidley KN; Loeffler BT; Mott SL; Hill EK; Erickson BA
Urology; 2021 Dec; 158():208-214. PubMed ID: 34582886
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
[TBL] [Abstract][Full Text] [Related]
4. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
5. Temporal Trends and Practice Patterns for Inpatient Management of Malignant Extrinsic Ureteral Obstruction in the United States.
Haas CR; Shah O; Hyams ES
J Endourol; 2020 Aug; 34(8):828-835. PubMed ID: 32340482
[No Abstract] [Full Text] [Related]
6. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
[No Abstract] [Full Text] [Related]
7. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
8. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction.
Nas OF; Oztepe MF; Kandemirli SG; Bilgin C; Ozkaya G; Inecikli MF; Kaygısız O
Abdom Radiol (NY); 2021 May; 46(5):2188-2194. PubMed ID: 33226456
[TBL] [Abstract][Full Text] [Related]
9. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer.
Spencer BA; Insel BJ; Hershman DL; Benson MC; Neugut AI
Support Care Cancer; 2013 May; 21(5):1303-11. PubMed ID: 23292697
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
13. Outcomes of distal ureteral reconstruction through reimplantation with psoas hitch, Boari flap, or ureteroneocystostomy for benign or malignant ureteral obstruction or injury.
Wenske S; Olsson CA; Benson MC
Urology; 2013 Jul; 82(1):231-6. PubMed ID: 23642933
[TBL] [Abstract][Full Text] [Related]
14. Contemporary role of ureterolysis in retroperitoneal fibrosis: treatment of last resort or first intent? An analysis of 50 cases.
O'Brien T; Fernando A
BJU Int; 2017 Oct; 120(4):556-561. PubMed ID: 28502080
[TBL] [Abstract][Full Text] [Related]
15. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
[TBL] [Abstract][Full Text] [Related]
16. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
17. A misplacement of a ureteral stent into the abdominal aorta: a case report of a rare retrograde ureteral stenting complication.
Prijovic N; Cegar B; Cvetic V; Santric V; Stankovic B; Radojevic J
BMC Womens Health; 2022 Nov; 22(1):458. PubMed ID: 36401287
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
Kim M; Hong B; Park HK
J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
[TBL] [Abstract][Full Text] [Related]
19. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
